|
Volumn 100, Issue 25, 1999, Pages
|
Diet drug maker agrees to $3.75 billion settlement.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEXFENFLURAMINE;
FENFLURAMINE;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG INDUSTRY;
HUMAN;
LEGAL ASPECT;
UNITED STATES;
VALVULAR HEART DISEASE;
DEXFENFLURAMINE;
DRUG INDUSTRY;
FENFLURAMINE;
HEART VALVE DISEASES;
HUMANS;
UNITED STATES;
MLCS;
MLOWN;
|
EID: 0033592829
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/01.cir.100.25.e133 Document Type: Article |
Times cited : (4)
|
References (0)
|